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Abstract
We investigated the effect of -174 G/C single-nucleotide polymorphism in the promoter region of the IL6 gene on plasma IL-6 
levels and muscle strength, and the relationship between IL-6 levels and muscle strength in elderly women. The sample con-
sisted of 199 elderly residents (73.0 ± 7.8 years old) from rest homes and the community in Belo Horizonte, MG, Brazil. -174 
G/C polymorphism was determined by direct sequencing of the product by PCR, and plasma IL-6 concentrations were measured 
by ELISA. Muscle strength in the knee joint was evaluated using a Biodex System 3 Pro® isokinetic dynamometer. ANCOVA 
was used to determine the effect of polymorphism on IL-6 levels and muscle strength, and the Pearson correlation coefficient 
to assess the relationship between IL-6 levels and muscle strength. -174 G/C polymorphism was associated with the plasma 
IL-6 levels of elderly women (P < 0.01) since homozygotes for the G allele showed high IL-6 levels (GG 3.85 pg/mL, GC + CC 
2.13 pg/mL). There was no association of polymorphism on muscle strength (P > 0.05). No association was found between 
IL-6 levels and knee extensor muscle (r = 0.087, P = 0.306) or flexor (r = -0.011, P = 0.894) strength. An interaction between 
-174 G/C polymorphism and housing conditions of the sample of elderly women was identified, with the effect of genotype on 
IL-6 levels being higher in the institutionalized elderly. These results support the evidence that -174 G/C polymorphism of the 
IL6 gene associates with individual variability of plasma IL-6 levels in elderly women.
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The aging process is associated with subliminal chronic 
inflammatory activity, with the occurrence of an idiopathic 
elevation of serum levels of inflammatory mediators such 
as interleukin-1 (IL-1), tumor necrosis factor-alpha (TNF-α), 
interleukin-6 (IL-6), and acute phase proteins such as C-
reactive protein (CRP), among other mediators (1,2). This 
subliminal state of inflammation has been linked to the 
pathological process of various age-related diseases and to 
the increased disability and mortality of the elderly (1-4).
IL-6 is a multifunctional pleiotropic cytokine with recog-
nized pro- and anti-inflammatory action. It plays an important 
role in the homeostasis of the immune and neuroendocrine 
systems, as well as in the balance of proinflammatory/anti-
inflammatory pathways and in response to stress (1,2,5). 
There is evidence that the concentration of IL-6 increases 
in the supernatant of peripheral blood mononuclear cell 
cultures and in the plasma of elderly individuals (1,6,7). 
Increased plasma IL-6 levels are associated with the pres-
ence of cardiovascular and rheumatic diseases, sarcopenia, 
functional decline, and mortality in the elderly (1,7,8).
The expression of IL-6 is related to its allelic variant (9). 
It is known that the IL6 gene has about 50 single-nucleotide 
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polymorphisms (SNP) in its promoter region, like the variants 
-597 G/A, -572 G/C, -373 A/T, and -174 G/C, among others 
(10-12). Several studies have questioned the functional 
role of the -174 G/C SNP in the production of IL-6 both in 
vivo (13-15) and in vitro (10-12). The change of guanine 
bases to cytosine (G → C) at position -174 seems to affect 
the transcription of the IL6 gene and therefore the plasma 
levels of this cytokine in young (10,12), elderly (12,13,15) 
and centenarian individuals (13,16). However, the results of 
studies regarding the activity and effects of polymorphisms 
on plasma levels of these mediators and susceptibility to 
different diseases are contradictory. 
Some evidence suggests that genetic factors may 
influence the physical functioning of elderly people since 
the hereditary factor for muscle strength may vary from 36 
to 65% (17-19). However, there is little information about 
specific genes that may contribute to the physical disability 
related to aging. In this respect, the genes involved in regu-
lating the inflammatory process, which increases with age, 
may contribute to individual variation in plasma cytokine 
levels and muscle strength in the elderly. However, despite 
evidence pointing at the action of IL-6 as one of the factors 
related to the reduction of muscle mass and muscle strength 
(sarcopenia) (1,20-22) and the importance of genetic varia-
tion in the regulation of this cytokine, studies investigating 
the impact of the -174 G/C polymorphism of the IL6 gene 
on the variables of muscle performance are scarce.
The objective of the present study was to investigate 
the effect of -174 G/C SNP in the promoter region of the IL6 
gene on plasma IL-6 levels and muscle strength in elderly 
women. The association between plasma IL-6 levels and 
muscle strength was also analyzed.
 
Material and Methods 
This was a cross-sectional observational study with a 
convenience sample consisting of elderly female residents 
of homes for the aged and in the community, in the city 
of Belo Horizonte. The study was approved by the Ethics 
Committee of Universidade Federal de Minas Gerais (ETIC 
322/07) and all volunteers gave written informed consent 
to participate, according to the principles of the Helsinki 
Declaration. 
Sample 
The sample was a convenience selection, whereby the 
participants were recruited by consecutive recruiting visits 
to homes for the aged, health centers and senior citizen 
social groups and by announcements in local homes for 
the aged and in the community. Exclusion criteria were: 
elderly people with acute phase inflammatory disease, using 
drugs that act on the immune system, presenting cognitive 
impairment detectable by the Mini-Mental State Examination 
(23), amputation or lower limb fracture in the last 6 months, 
and the presence of neurological sequelae.
For sampling in the community, 455 potential volunteers 
were initially contacted, and 153 elderly subjects were se-
lected on the basis of the inclusion and exclusion criteria. 
Of these, 8 dropped out: 4 because of health problems 
(cataract surgery, erysipelas, deep vein thrombosis, and 
cardiac abnormalities) and 4 because of transportation dif-
ficulties to reach the site of assessment. The total number 
of elderly subjects was 145, who were from the community. 
Due to the high prevalence of cognitive disorders, sickness 
in the acute phase, use of medications acting on the im-
mune system and refusal of some homes for the aged to 
participate, the sample from homes for the aged consisted 
of only 57 elderly women. Therefore, with the elderly from 
the community and the homes for the aged, a total of 202 
participants were selected for the study.
To characterize the sample, the sociodemographic data 
(age, marital status, education, and personal income) and 
information on the clinical conditions of the elderly (comor-
bidities, number and type of medications, body mass index 
(BMI), presence of pain, walking capacity, and occurrence 
of falls in the previous year) were obtained using a struc-
tured questionnaire and a clinical assessment, carried out 
by trained personnel. 
Muscle strength
Muscle strength was assessed using a Biodex® System 
3 Pro isokinetic dynamometer (Biodex Medical Systems 
Inc., USA). The muscle groups assessed were the knee 
joint extensors and flexors of the dominant limb. Work 
was standardized according to body mass, selected as a 
parameter of muscle performance, and was obtained by 
means of concentric contractions at an angular velocity of 
60°/s, with five repetitions. All procedures were performed 
according to the assessment protocol suggested by the 
manufacturer, such as positioning of the volunteer, calibra-
tion, correction for gravity, familiarization, and strong verbal 
encouragement (24). Considering the difficulties in selecting 
and transporting the institutionalized elderly to the place of 
assessment, muscle strength was measured only in the 
elderly from the community.
IL-6 levels
Five milliliters of blood was collected from the ulna vein 
of the participants into Vacutainers with citrate by a qualified 
healthcare professional. The blood was then centrifuged and 
the plasma was removed in a sterile environment and stored 
in Eppendorf tubes in a freezer at -70°C for 2 years. 
Plasma IL-6 concentrations were measured by ELISA 
using high sensitivity kits from Quantikine® HS, R&D Sys-
tems, USA, according to manufacturer recommendations. 
Measurements were made in duplicate and results are 
reported as means ± SD. The intra-assay coefficient of 
variation was 6.9-7.4%, the interassay coefficient of varia-
tion was 9.6-6.5%, and sensitivity was 0.016-0.110 pg/mL 
(mean: 0.039 pg/mL). Data are reported as picograms per 
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mL (pg/mL). Absorbance was measured using a single 
microplate reader at 490 nm with length correction at 650 
nm (Microplate Reader Asys, Austria). 
Identification of genotype
Total DNA was isolated from peripheral plasma samples 
using the QIAamp DNA Mini-Kit (Qiagen, USA) according 
to manufacturer recommendations. The -174 G/C polymor-
phism in the promoter region of the IL6 gene (rs1800795) 
was determined by direct sequencing of the product of a 
polymerase chain reaction (PCR). A 628-bp region of the 
IL6 gene containing the polymorphic point was amplified 
using a specific pair of primers: 5’-GAACACAGAAGAACTC 
AGATGACTGG-3’ (sense) and 5’-AGGAGTTCATAGCTGG 
GCTCCTGGAG-3’ (antisense). The reactions were per-
formed in tubes containing 100 ng DNA, 10 mM Tris-HCl, 
pH 9.2, 25 mM KCl, 1.5 mM MgCl2, 0.2 mM dNTP, 20 pmol 
of each primer, 0.5 µg purified albumin (purified chicken 
albumin) and one unit of Taq polymerase DNA (Phoneutria, 
Brazil) in a final volume of 50 µL. After 1 min of initial heat-
ing at 80°C and an initial denaturation for 2 min at 94°C, 
amplification was performed for 36 cycles of 40 s at 94°C, 
45 s at 64°C, and 50 s at 72°C, followed by 5 min at 72°C. 
A sample (100 ng) of each PCR product was sequenced 
directly with an ABI PRISM 3700 DNA analyzer (Applied 
Biosystems, USA) using the DYEnamic ET Terminator 
Cycle Sequencing Kit (GE Healthcare, UK) along with 2 
µM of the 5’-GCCTCAGAGACATCTCCAGTCC-3’ primer 
in the reaction tube. Sequencing condi-
tions using a PE 9700 thermal cycler 
(Perkin Elmer, USA) were as follows: 30 
cycles of 20 s at 95°C, 15 s at 50°C, and 
1 min at 60°C. Each sequence obtained 
was examined using the Staden software 
package (MRC, UK) and confirmed by 
visual inspection.
Statistical analysis
The description of the subject sample 
was done by measuring central tendency 
(means ± SD) and frequency of the socio-
economic and clinical variables. Violation 
of Hardy-Weinberg equilibrium was tested 
by the chi-square test, taking P < 0.05. 
The effect of polymorphism on IL-6 
levels and muscle strength in the elderly 
women was investigated by analysis of 
covariance (ANCOVA). Considering the 
heterogeneity of the sample and the 
known association of some variables with 
plasma IL-6 indexes and muscle strength, 
a covariance test was performed in which 
IL-6 levels were considered as dependent 
variable regarding genotype, housing 
conditions (institutionalized or living in the 
community) and the presence of osteoarthritis constituted 
the fixed factors (independent). Age and BMI were used 
as covariants. 
The Pearson correlation coefficient (r) was used to 
assess the correlation between plasma IL-6 levels and 
muscle strength. Data normality was checked by the 
Kolmogorov-Smirnov test and homogeneity of variances 
by the Levene test. The level of significance was set at α 
= 0.05 in all analyses. Analyses were performed using the 




Of the 202 elderly subjects from the community and 
homes for the aged that met the inclusion criteria, 199 
participated in the study, 55 of them residents of homes 
for the aged and 144 residents of the community. Three 
elderly women (2 institutionalized and 1 from the commu-
nity) were excluded because it was not possible to obtain 
their genotype for the -174 G/C polymorphism of the IL6 
gene. The sociodemographic and clinical characteristics 
of the total sample are presented in Table 1. 
The genotypes were consistent with Hardy-Weinberg 
equilibrium proportions (58% GG, 39% GC, and 3% 
CC; P > 0.05). The frequency of genotypes for the -174 
G/C polymorphism and the plasma levels of IL-6 are 
presented in Table 2. For analysis, the genotypes were 
Table 1. Sociodemographic and clinical characteristics of the elderly women as-
sessed.
Variable Home for the aged
N = 55 (28%)
Community
N = 144 (72%)
Total sample
N = 199
Age (means ± SD) 77.4 ± 9.5 71.3 ± 6.2 73.0 ± 7.8
Educational level 
No schooling 13 (24%) 13 (9%) 26 (13%)
1 to 7 years of schooling 31 (56%) 63 (11%) 94 (47%)
8 or more years of schooling 11 (20%) 68 (47%) 79 (40%)
Marital status
Single 35 (64%) 6 (4%) 41 (21%)
Married 0 59 (41%) 59 (30%)
Widow 17 (31%) 57 (40%) 74 (37%)
Divorced 3 (5%) 22 (15%) 25 (13%)
Income 
<2 minimum wages* 51 (93%) 46 (32%) 96 (49%)
2-3.99 minimum wages 4 (7%) 51 (35%) 55 (28%)
≥4 minimum wages 0 46 (32%) 46 (23%)
BMI (kg/m2) 25.3 ± 5.5 28.9 ± 4.7 28.0 ± 5.2 
Osteoarthritis 26 (47%) 113 (79%) 139 (70%)
HBP 27 (49%) 91 (63%) 118 (59%)
*Minimum wage for 2010 = R$510.00 (US$238.31 to US$305.38). The categorical 
variables (educational level, marital status and income) are reported as frequency 
and percentage. BMI = body mass index; HBP = high blood pressure.
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grouped as GG vs GC + CC. 
The difference in mean plasma IL-6 levels was significant 
between the groups of genotype GG vs GC + CC, with the 
elderly women with the GG genotype having higher levels 
of this cytokine when compared with carriers of the C al-
lele (ANCOVA). The effect of polymorphism on IL-6 levels 
was significant even under the influence of, and interaction 
between, the housing condition variables (homes for the 
aged or community), and the presence of osteoarthritis and 
BMI were controlled (F = 10.99; P < 0.01). 
In the analysis of variance of IL-6 levels attributed to 
genotype and housing condition factors, the polymorphism 
showed a higher relative effect of IL-6 levels (partial η2 = 
0.058), which, however, was lower than the effect of the 
housing conditions on this mediator (partial η2 = 0.189). 
Moreover, an interaction between residing status and -174 
G/C polymorphism (F = 5.84; P = 0.02) was observed, with 
the effect of genotype on IL-6 levels being higher in the 
institutionalized elderly compared to the elderly women from 
the community. Comparison of IL-6 levels between groups of 
genotypes (GG vs GC + CC) revealed more marked levels 
in the institutionalized elderly women compared to those 
living in the community (P < 0.05; Table 3).
To analyze the effect of polymorphism on muscle 
strength, 139 of 144 elderly women from the community 
were assessed using an isokinetic dynamometer, and 5 
dropped out during this phase of the study. No difference 
was observed in the muscle strength of knee joint exten-
sors and flexors, assessed according to work/body mass 
in the elderly from the community, between groups of 
genotypes (GG vs GC + CC) (P > 0.05). Similarly, no cor-




Results obtained for the sociodemographic profile 
and the clinical population studied were consistent with 
literature report regarding low education and low income. 
The sample presented a tendency toward excess weight 
according to Lipschitz (25) cutoff points for the elderly, and 
the prevalence of osteoarthritis was high. 
Analysis of covariance showed that the -174 G/C poly-
morphism affected the plasma IL-6 levels of elderly women 
regardless of whether they resided in the community or were 
institutionalized (P < 0.01). Higher IL-6 levels were observed 
in the group of elderly women with the GG genotype, as 
also observed in another recent Brazilian study (26). This 
effect was significant even when factors related to IL-6 
levels were controlled, such as the following variables: 
housing conditions (homes for the aged or community), 
presence of osteoarthritis, age and BMI. However, the 
housing condition variable for the elderly women strongly 
affected the plasma IL-6 levels, with institutionalized women 
presenting comparatively higher IL-6 levels than women 
from the community. 
The institutionalized elderly women usually represent 
a distinct population: they have more associated diseases, 
comorbidities, a higher prevalence of depression and dif-
ficulty to perform daily tasks. Moreover, they live without a 
multigenerational family and social contact and are submit-
ted to a routine and to interventions that are peculiar to the 
institution where they live. Research has documented the 
impact of the social support network on the dysregulation 
of physiological parameters, where there is a lack of this 
association with morbidity and mortality (27,28). Growing 
evidence points to a relationship between social conditions 
and adverse environmental conditions and high levels of 
inflammatory mediators (27,28). Due to this, the living 
conditions of institutionalized elderly women can contribute 
to a chronic condition of biopsychosocial stress, which in 
turn can influence the plasma levels of proinflammatory 
mediators. These factors could explain the impact of insti-
tutionalization on the increased plasma IL-6 levels in the 
sample studied.
In the present study, a significant interaction effect 
between genotype and housing conditions of the elderly 
was also observed. The institutionalized elderly showed 
higher levels of plasma IL-6 compared to those living in 
the community, indicating that the effect of genotype on 
Table 2. Distribution of genotypes and plasma IL-6 levels in el-
derly women living in homes for the aged or in the community.
Variable Home for the aged Community Total sample
GG 34 (62%) 82 (57%) 116 (58%)
GC 20 (36%) 58 (40%)  78 (39%)
CC 1 (2%) 4 (3%)  5 (3%)
Plasma IL-6 
(pg/mL)
6.37 ± 6.31 1.87 ± 2.49 3.13 ± 4.40
Data are reported as means ± SD. IL-6 = interleukin-6.
Table 3. Comparison of IL-6 levels between groups of genotypes 
GG vs GC + CC for IL6 gene -174 G/C polymorphism.
 
Variable Plasma IL-6 (pg/mL) ANCOVA
Home for the aged Community F P 
GG 7.74 ± 6.5 2.24 ± 2.3 5.84 0.02*
GC + CC 4.17 ± 3.4 1.36 ± 1.3
Data are reported as means ± SD. Comparison of IL-6 levels 
between groups of genotypes (GG vs GC + CC) revealed more 
marked levels in elderly women living in homes for the aged 
compared to those living in the community (F = 5.84; P = 0.02). 
IL-6 = interleukin-6.
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IL-6 levels appears to be greater in the institutionalized 
elderly. Recent studies have shown that the control of 
the expression of IL-6 is extremely complex, being regu-
lated by different mechanisms and factors (9,11,29). The 
promoter region of IL6 genes behaves as a sophisticated 
biosensor regarding the homeostasis of the immune 
system, hormonal changes and different environmental 
factors such as diet and stress conditions as determined 
by lifestyle, social and psycho-emotional issues (30). 
In this context, the condition of institutionalization of 
elderly women could lead to imbalances of a nutritional 
and psychosomatic nature with inflammatory repercus-
sions, causing the effect of a genotype prone to a higher 
production of cytokines. 
However, even being influenced by environmental fac-
tors, the effect of -174 G/C polymorphism on IL-6 levels was 
significant for both the institutionalized and community-living 
elderly women. Indeed GG homozygous individuals showed 
higher levels of IL-6 even in distinct social and environ-
mental conditions, providing evidence that this genotype 
interfered significantly with plasma IL-6 levels in the sample 
studied. These findings provide further support for literature 
data showing that the -174 GG genotype is associated 
with greater production of IL-6 both in vitro (10,12) and in 
vivo (12,13), but they differ from reports showing that this 
genetic influence is dependent on gender (12). Olivieri et 
al. (12) analyzed the effect of -174 G/C polymorphism on 
the production of IL-6 in vitro and in vivo in a sample of 62 
individuals aged 29 to 93 years. A significant association 
between -174 G/C polymorphism and the production of IL-6 
was observed both in vitro and in vivo, with GG individuals 
presenting higher IL-6 levels than CC + GC subjects, with a 
significant association only for males. These results agree 
with those reported by Bonafé et al. (13). However, infor-
mation regarding gender specificities is limited, but there 
are indications of possible interactions between genes and 
sex hormones (31). 
Other investigators, studying the association between 
-174 G/C polymorphism and specific diseases and longevity, 
have obtained contradictory results regarding genotypes 
(14,16,32,33). Rea et al. (34) evaluated changes in the 
frequency of GG homozygotes for polymorphism at position 
-174 G/C of the gene for IL-6 with aging and observed a 10% 
decline in the frequency of this genotype with advancing 
age, with homozygotes for the C allele presenting higher 
IL-6 levels. A study consistent with these results was con-
ducted on individuals older than 80 years, with follow-up for 
a period of 6 years, where the C allele was associated with 
high levels of plasma IL-6 in octogenarians (14). 
An important question should be considered regarding 
the conflicting results in the literature. The aging process and 
the health conditions related to age are complex phenotypes, 
influenced by the interaction between genes and different 
environmental factors. The different results observed among 
studies were possibly due to the interactions between 
lifestyle and genetic factors, along with cultural and ethnic 
differences across different countries. 
There is little research on the impact of the -174 G/C 
polymorphism of the IL6 gene on muscle performance 
variables. In the present study, no effect of -174 G/C poly-
morphism of the IL6 gene was observed on muscle strength 
of knee extensors and flexors, assessed by the work/body 
mass of elderly women in the community. These results 
support other results reported in the literature (35,36). 
Roth et al. (35) investigated the association between -174 
G/C polymorphism of the IL6 gene and muscle mass and 
strength in 242 individuals (110 men and 132 women) 
aged 21 to 92 years. These investigators found an as-
sociation of this polymorphism with muscle mass, but not 
with muscle strength (35). Walston et al. (36) investigated 
the association of different alleles of the IL6 gene with 
variables such as plasma IL-6 levels, muscle strength and 
fragility, in two cohorts of elderly subjects. No relationship 
was demonstrable between plasma IL-6 levels, muscular 
strength (handgrip and isometric strength of knee extensors 
and hip flexors) and weakness and the polymorphisms or 
the haplotypes investigated for the IL6 gene, including the 
-174 G/C polymorphism.
However, these findings should be interpreted with 
caution since an approach focused on the polymorphism 
of a single inflammatory mediator is limited. Other media-
tors besides IL-6 play an important catabolic role in muscle 
and, likewise, their levels are influenced by functional 
polymorphisms in the promoter region of their genes, such 
as TNF-α. Another point to be considered is that possible 
interactions between genes of these cytokines may contrib-
ute to the variability in muscle performance observed with 
age, and mask the separate effects of a single polymor-
phism. This requires a more detailed investigation of the 
complex interactions between polymorphisms of different 
genes and their influence on specific phenotypes, such as 
muscle strength. 
Laboratory and clinical studies have shown that high 
levels of IL-6 are associated with a reduction of muscle 
mass and strength in the elderly (8,37,38). The mechanism 
by which these cytokines contribute to muscle alteration is 
not known, but involves its catabolic action on muscle, with 
a reduction of myofibril protein being related to sarcopenia 
(8). However, in the present sample of community-living 
elderly women, no correlation was observed between 
muscle strength and plasma IL-6 levels. This result may 
be explained by the fact that the plasma levels found in the 
elderly assessed here (1.87 ± 2.49 pg/mL) did not reach the 
threshold necessary to influence muscle performance. In a 
cohort of 627 elderly women presenting moderate to severe 
disabilities, Ferrucci et al. (37) found that those with plasma 
IL-6 levels in the highest tertiles (IL-6 >3.1 pg/mL) showed 
a greater reduction of knee extensor muscle strength and 
also of the ability to perform daily activities.
Some limitations of the present study should be consid-
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ered. The fact that it was a convenience sample does not 
permit to generalize the results, limiting its external validity. 
Another point to be considered is that the level of physical 
activity of the elderly women was not recorded. There is 
evidence that physical activity has an anti-inflammatory 
effect, with a reduction in plasma levels of inflammatory 
mediators, so that physically active individuals present 
lower levels of plasma IL-6. IL-6 is released during physical 
exercise, produced by the muscle (myocyte) and is ac-
companied by the synthesis of anti-inflammatory cytokines 
such as IL-1ra, a soluble TNF-α receptor (sTNFR) and 
IL-10. Moreover, physical activity has been shown to be 
an effective strategy for the prevention and treatment of 
sarcopenia (39,40). Thus, the practice of physical activity, if 
carried out by participants, may have influenced the results 
found regarding the effect of genotypes on muscle strength, 
and may have contributed to the lower levels of IL-6 found 
in the elderly women from the community.
The results of this study support the evidence that the 
-174 G/C polymorphism of the IL6 gene influences the 
levels of plasma IL-6 in elderly residents of homes for the 
aged and in the community. This effect persisted even 
when the influence and interactions between factors known 
to interfere with the production of IL-6 were controlled. 
Moreover, an interaction between -174 G/C polymorphism 
and the housing conditions of the women was identified, 
suggesting that environmental factors may modulate the 
effects of genotypes on the production of IL-6. No effect of 
polymorphism was observed on the muscle strength of the 
extensors and flexors of the knee joint and no association 
was found between plasma IL-6 levels and muscle strength 
in elderly women from the community.
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